Despite preclinical evidence suggesting that CRF1 antagonists would be efficacious in the treatment of alcohol dependence, clinical trials of CRF1 antagonist-based therapies to treat AUD in humans have shown mixed results [22,23]. The gene discussed is CRHR1; the disease is alcohol dependence.